NIH

SMU Professor Gets $1.8M NIH Award to Study How Bodies May Work to Repair Cells

by | Sep 18, 2023
The award will help SMU biology professor Zhihao Wu determine if different "quality control pathways" in our bodies might be working together to repair damaged components in cells. The research could help lead to "new therapeutic targets" for hallmarks known to cause many human diseases, the university said.
MORE
The Last Word: Macrocyclics Founder Dr. A. Dean Sherry on His Company’s Impact on Nuclear Medicine
A holder of 34 patents, Sherry was a pioneer in designing molecular materials for use in medical imaging. His work on chemicals called macrocyclic ligands led to their use in carrying "a payload of metallic radiotherapeutic compounds that can kill cancer cells on contact, while the outside molecular structure can be designed to bind to a specific protein that ensures precise delivery to only diseased tissue," Amanda Siegfried writes in UT Dallas Magazine.
MORE
UT Southwestern Is Selected as One of 12 NIH Obesity Research Centers
by | Sep 28, 2022
Over 150 scientists across dozens of departments will be part of the elite National Institutes of Health-funded, university-wide interdisciplinary research center. Dallas' UT Southwestern Medical Center is the only institution in Texas to be selected for the NIH initiative.

UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
MORE
UTD Team Develops Rapid Virus Test That’s ‘150 Times More Accurate’—and They’ve Launched a Company to Commercialize It
by | Apr 21, 2022
A team of UT Dallas bioengineers has developed a rapid test for viruses that delivers results as accurate as PCR lab tests within 30 minutes. The test works by attaching gold nanoparticles to antibodies against the virus being tested, then scanning them with two lasers.

Three months after winning the grand prize at the MassChallenge North Texas pitch competition, the team's leader, Dr. Zhenpeng Qin, is working to commercialize the technology through a new company, Avsana Labs.
MORE

Two TechFW Clients Receive Awards from NASA and the National Eye Institute

by | Jun 1, 2020
DesignPlex Biomedical was given a royalty-free license by NASA to commercialize a new ventilator for coronavirus patients. Nanoscope Technologies got more than $2 million from the National Eye Institute to advance its gene therapy treatment.
MORE
biotech
Dallas to Host Federal BioTech Conference
by | Apr 27, 2018
Local startups and researchers can learn how to get federal research-and-tech-driven grant funding and meet federal experts in this conference hosted by the Dallas Regional Chamber. 
MORE
Eye
UNT Researchers Testing Drug to Prevent Blindness Caused by Glaucoma
by | Nov 17, 2016
Glaucoma is the second leading cause of blindness.
MORE